|
Match
|
Document |
Document Title |
|
|
7642230 |
Zinc-containing sustained-release composition, its preparation, and method for producing the same
With a simple and high-yield production method, a zinc-containing sustained-release composition capable of stabilizing a physiologically active protein or peptide, typically G-CSF by precipitation...
|
|
|
7638524 |
Combination therapy for treating hypercholesterolemia
The invention relates to methods for treating hypercholesterolemia and atherosclerosis, and reducing serum cholesterol in a mammal. The methods of the invention comprise administering to a mammal a...
|
|
|
7638335 |
Kit comprising antihuman TNF-α antibody and antihuman TNF-α antibody activity lowering inhibitor
The present invention provides an antihuman TNF-α antibody activity lowering inhibitor comprising a protein source(s) and/or carbohydrate source(s), in the treatment of inflammatory bowel syndrome ...
|
|
|
7635675 |
Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
Fatty acid salt particles having a size distribution wherein the particles are from about 1 to about 1,000 microns in diameter, use of the particles in pharmaceutical compositions, as well as...
|
|
|
7632853 |
Soluble, stable and concentrated pharmaceutical composition compromising ritonavir and process for preparing thereof
The present invention describes a soluble stable pharmaceutical composition for the administration of HIV protease inhibitors. More specifically the composition comprises a solution of an HIV...
|
|
|
7628985 |
Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
Pharmaceutical formulations of glutenase enzymes are provided. The enzymes find particular use in the treatment of a Celiac or dermatitis herpetiformis patient.
|
|
|
7628997 |
Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations
The method of preserving a perishable cosmetic and/or pharmaceutical preparation includes adding bioactive glass particles to the preparation, preferably in amounts up to 10 percent by weight. The...
|
|
|
7625898 |
Posaconazole polymer conjugates and methods of treatment using posaconazole and polymer conjugates thereof
Improved posaconazole-based compositions and methods of treating and preventing fungal infections, cancer or metastatic diseases are disclosed. In preferred aspects, the conjugates are...
|
|
|
7625579 |
Antimicrobial coatings
The present invention provides a substrate having a plurality of immobilised furanone moieties associated with at least part of a surface of the substrate. The invention also relates to articles...
|
|
|
7622129 |
Nano-structured polymers for use as implants
Polymeric materials and processes for making the same are provided herein wherein said polymeric materials have nano-sized topological features or textures. These features have dimensions in...
|
|
|
7618643 |
Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
The present invention features hydrogel drug delivery systems and methods of producing and using such systems for the treatment of wounds. The systems are based on a hydrogel into which a low...
|
|
|
7618659 |
Production of canola protein
A canola protein isolate having a protein content of at least about 90 wt % (N×6.25), preferably at least about 100 wt %, and consisting predominantly of the 2S protein and substantially free from ...
|
|
|
7618615 |
Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia
Methods and pharmaceutical compositions for preconditioning and/or providing neuroprotection to the animal central nervous system against the effects of ischemia, trauma, metal poisoning and...
|
|
|
7615238 |
Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
The present invention relates to plasters for prophylaxis and/or treatment of a dysfunction or disorder of nails, especially onychomycosis, onychocryptosis, nail psoriasis, melanonychia striata,...
|
|
|
7611723 |
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
A stinging cell comprising an exogenous polynucleotide capable of expressing a therapeutic, cosmetic or diagnostic agent in the stinging cell is provided.
|
|
|
7611722 |
Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
A solid dosage form for oral administration to a patient comprising a core tablet sheathed in an annular body of compressed powder or granular material is provided. A preferred embodiment of the...
|
|
|
7612102 |
Pre-mixed, ready-to-use pharmaceutical compositions
Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular...
|
|
|
7608250 |
Cosmetic composition
A cosmetic composition for skin and/or hair, which comprises at least one kind of substance selected from the group consisting of an Nα,NG-di-acylarginine, for example, a compound represented by ...
|
|
|
7608640 |
Glycine betaine and its use
The present invention provides pharmaceutical uses of betaines, and especially glycine betaine, such as for the treatment of thromboses not induced by hyperhomocystenemia or homocystinuria, of...
|
|
|
7608454 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Vascularization enhanced graft constructs
A tissue graft construct for use in repairing diseased or damaged tissues is provided. The tissue graft construct comprises a matrix composition selected from the group consisting of liver basement...
|
|
|
7601361 |
Process for providing antimicrobial surfaces
Processes for providing durable antimicrobial surfaces are disclosed that comprise treating a polymer substrate surface with formaldehyde followed by treatment with an antimicrobial peptide....
|
|
|
7601360 |
Excitatory amino acid inhibitors for treating sensitive skins
Sensitive human skin/scalp/mucous membrane conditions, for example skin irritation and/or dry patches and/or erythemas and/or dysaesthesic sensations and/or sensations of heating and/or pruritus,...
|
|
|
7597897 |
Medicinal compositions and method for the preparation thereof
Methods for the manufacture of medicinal compositions are described. A method for the manufacture of a medicinal composition according to the invention comprises: (a) Providing a biocompatible...
|
|
|
7595079 |
Nutritional conjunctive support therapy for recovery in animals following stress or illness
A composition of probiotics, vitamins and minerals, electrolytes with glutamine and glucose along with medium chain triglycerides are provided as a supplement to animals. This is administered to...
|
|
|
7595065 |
Breath freshening and oral cleansing products with synergistic combinations of magnolia bark extract and essential oils
An oral composition for oral cleansing, breath freshening, and anti-microbial benefits includes an oral cavity delivery agent and an antimicrobial active agent including a synergistic combination...
|
|
|
7592000 |
Method of tanning human body by mysting or immersion at elevated temperature
The present invention relates to the use of self-tanning substances for application to the human skin, with application taking place at elevated temperature, to corresponding methods of application...
|
|
|
7592020 |
Personal care products with visual indicator of vaginitis
There is provided a personal care product having a body side liner, a baffle and an indicator strip with two ends. The indicator has an amine sensitive dye near at least one end. The indicator...
|
|
|
7588786 |
Eutectic-based self-nanoemulsified drug delivery system
A eutectic-based self-nanoemulsified drug delivery system (SNEDDS) is formulated from polyoxyl 35 castor oil (Cremophor), medium chain mono- and diglycerides (capmul), essential oils, and a...
|
|
|
7588781 |
Method for increasing bioavailability of lipophilic bioactive compounds
A primary composition that includes at least one lipophilic bioactive compound and a whey protein in an amount effective to increase the bioavailability of the lipophilic bioactive compound, and...
|
|
|
7582312 |
Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
Methods of producing lung surfactant formulations through solvent dissolution and lyophilization are described as well as surfactant formulations derived therefrom. Methods of treating respiratory...
|
|
|
7578997 |
Metal ion modified high surface area materials for odor removal and control
This invention relates to high surface area materials, such as nanoparticles, that are coated with metal ions. These modified nanoparticles have active sites that bind various gases and/or odorous...
|
|
|
7579014 |
Mesoporous compositions for use in drug delivery
The present invention encompasses novel mesoporous compositions comprising vitamin E and alumina, and methods for their synthesis. The mesoporous compositions of the present invention have...
|
|
|
7579013 |
Formulations for coated microprojections containing non-volatile counterions
The invention provides for a formulation for coating one or more microprojections which reduces or minimizes the loss of counterions from the coating in order to achieve a pH-stabilized formulation.
|
|
|
7572463 |
Oral dosage forms
A controlled-release oral dosage formulation of a salt-forming active ingredient, wherein the active ingredient is present as at least two different salts in a solid aggregation state, wherein the...
|
|
|
7572458 |
Boron compound-layered double hydroxide nanohybrid, method of preparing the boron compound-LDH nanohybrid, and pharmaceutical composition comprising the boron compound-LDH nanohybrid
Provided are a boron compound-layered double hydroxide (LDH) nanohybrid in which a boron compound for boron neutron capture therapy is intercalated in between layers of LDH, a method of preparing...
|
|
|
7563451 |
Capped mesoporous silicates
The invention provides an article comprising, a mesoporous silicate matrix, such as a particle, having one or more pores; and one or more releasable caps obstructing one or more of the pores. The...
|
|
|
7563818 |
Photosensitizer functionalised nanoparticles
The present invention relates to self-assembly of a photosensitizer on a nanoparticle. The invention also provides methods for production of functionalized (eg. stabilized) nanoparticles. The...
|
|
|
7560493 |
Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer
The invention relates to a composition for topical use containing, in a physiologically acceptable medium having an aqueous phase, at least one oxidation-sensitive hydrophilic active principle and...
|
|
|
7556822 |
Biomedical compositions
A method of preparing intraocular lenses in situ is disclosed. The method involves the injection of an unsaturated macromonomer of Formula I: The macromonomer is then polymerized to give a polymer...
|
|
|
7556818 |
Composition for and method of treating psoriasis
A composition and method of applying to skin which has psoriasis a gel that contains curcumin and/or curcuminoids. Prior to applying of the gel to the skin, the affected layer is soaked in...
|
|
|
7556800 |
Universal fishing bait based on filaments or strips of fibrous collagen
The current invention involves a universal fishing bait fundamentally comprised of a cord body of filaments or strips of fibrous collagen made up into any shape or design capable of attracting...
|
|
|
7553495 |
Liquid compositions comprising oxyalkylated polyglycerol esters
Compositions are described which comprise oxyalkylated polyglycerol esters, one or more organic solvents and water. The compositions are exceptionally suitable for the thickening of...
|
|
|
7553482 |
Use of a phosphate adsorbent to combat vascular diseases
The invention relates to the use of an adsorption material which has been modified with polynuclear metal oxide hydroxides for influencing the calcium level and, in particular, for treating or/and...
|
|
|
7550157 |
Method for the preparation of polymeric micelle via phase separation of block copolymer
A method for preparing a biodegradable polymeric micellar composition using liquid polyethylene glycol as a phase separation medium. The present invention also provides an efficient method to...
|
|
|
7547471 |
Material for implantation
The present invention relates to a material for implantation, which is characterised in that the surface of the material partially comprises at least one area of an inorganic, catalytical substance...
|
|
|
7547453 |
Method of production of material for treating mammalian joint maladies by biological fluid transplantation
Disclosed is a product and method for transplanting biological fluids into a host animal (including humans) that have been collected from donor animals. These biological fluids have been purified...
|
|
|
7547449 |
Method for treating a bone defect with an organic/inorganic composite
The subject invention concerns a composite comprising an organic fluid-swellable, fibrous matrix, such as collagen, and a mineral phase, such as calcium carbonate or phosphate mineral phase, for...
|
|
|
7544656 |
Long acting injectable insulin composition and methods of making and using thereof
A method of lowering blood glucose in a mammal includes injecting a therapeutically effective amount of crystallized dextran microparticles and insulin to the mammal to lower blood glucose of the...
|
|
|
7544367 |
Chemical method of making a suspension, emulsion or dispersion of pyrithione particles
A method for producing a suspension, emulsion or dispersion of de-agglomerated particles (advantageously submicron-sized particles) of pyrithione salts comprising contacting agglomerated pyrithione...
|
|
|
7541167 |
Porous glass composite material
A porous glass composite material comprising at least one alkoxodisilane (precursor) having the general formula (or1)3Si-spacer-Si(OR2)3,wherein R1 and R2 are the same or different and may be...
|